These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37521856)

  • 1. Erratum: Author correction to "DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis" [Acta Pharmaceutica Sinica B 12 (2022) 262-273].
    Wang Y; Wei B; Wang D; Wu J; Gao J; Zhong H; Sun Y; Xu Q; Liu W; Gu Y; Guo W
    Acta Pharm Sin B; 2023 Jul; 13(7):3177. PubMed ID: 37521856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage repair promotion in colonic epithelial cells by andrographolide downregulated cGAS‒STING pathway activation and contributed to the relief of CPT-11-induced intestinal mucositis.
    Wang Y; Wei B; Wang D; Wu J; Gao J; Zhong H; Sun Y; Xu Q; Liu W; Gu Y; Guo W
    Acta Pharm Sin B; 2022 Jan; 12(1):262-273. PubMed ID: 35127384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Erratum: Author correction to 'Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models' [Acta Pharmaceutica Sinica B 11(2021) 1903-1913].
    Yu Z; Kong D; Liang Y; Zhao X; Du G
    Acta Pharm Sin B; 2023 Feb; 13(2):899-901. PubMed ID: 36873189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Author correction to 'Protective effects of VMY-2-95 on corticosterone-induced injuries in mice and cellular models' [Acta Pharmaceutica Sinica B 11 (2021) 1903-1913].
    Yu Z; Kong D; Liang Y; Zhao X; Du G
    Acta Pharm Sin B; 2023 Aug; 13(8):3579-3580. PubMed ID: 37655326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erratum: Author correction to 'Approved HIV reverse transcriptase inhibitors in the past decade' [Acta Pharmaceutica Sinica B 12 (2022) 1567-1590].
    Li G; Wang Y; De Clercq E
    Acta Pharm Sin B; 2023 Aug; 13(8):3581. PubMed ID: 37655322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erratum: Author correction to 'Cardamonin from a medicinal herb protects against LPS-induced septic shock by suppressing NLRP3 inflammasome' [Acta Pharmaceutica Sinica B 9 (2019) 734-744].
    Wang Z; Xu G; Gao Y; Zhan X; Qin N; Fu S; Li R; Niu M; Wang J; Liu Y; Xiao X; Bai Z
    Acta Pharm Sin B; 2020 Dec; 10(12):2433-2434. PubMed ID: 33354512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erratum: Author correction to 'Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing
    Zhang W; Pan X; Xu Y; Guo H; Zheng M; Chen X; Wu H; Luan F; He Q; Ding L; Yang B
    Acta Pharm Sin B; 2023 Oct; 13(10):4337. PubMed ID: 37799392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erratum: Author correction to "Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers" [Acta Pharmaceutica Sinica B 11 (2021) 355-372].
    Jiang T; Wang G; Liu Y; Feng L; Wang M; Liu J; Chen Y; Ouyang L
    Acta Pharm Sin B; 2022 Jun; 12(6):2963-2964. PubMed ID: 35755289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum: Author correction to 'Ablation of Akt2 and AMPK
    Wang S; Tao J; Chen H; Kandadi MR; Sun M; Xu H; Lopaschuk GD; Lu Y; Zheng J; Peng H; Ren J
    Acta Pharm Sin B; 2023 Feb; 13(2):897-898. PubMed ID: 36873171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erratum: Author correction to 'TMEM16A inhibits angiotensin II-induced basilar artery smooth muscle cell migration in a WNK1-dependent manner' [Acta Pharmaceutica Sinica B 11 (2021) 3994-4007].
    Zheng H; Li X; Zeng X; Huang C; Ma M; Lv X; Zhang Y; Sun L; Wang G; Du Y; Guan Y
    Acta Pharm Sin B; 2023 Sep; 13(9):3956-3960. PubMed ID: 37719376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Author correction to 'Establishment of pseudovirus infection mouse models for
    Chen Q; Tang K; Zhang X; Chen P; Guo Y
    Acta Pharm Sin B; 2020 Aug; 10(8):1586-1587. PubMed ID: 32963952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erratum: Author correction to 'Multifunctional regulatory protein connective tissue growth factor (CTGF): A potential therapeutic target for diverse diseases' [Acta pharmaceutica sinica B 12 (2022) 1740-1760].
    Fu M; Peng D; Lan T; Wei Y; Wei X
    Acta Pharm Sin B; 2022 Dec; 12(12):4525. PubMed ID: 36562005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum: Author correction to "YPD-30, a prodrug of YPD-29B, is an oral small-molecule inhibitor targeting PD-L1 for the treatment of human cancer" [Acta Pharmaceutica Sinica B 12 (2022) 2845-2858].
    Lai F; Ji M; Huang L; Wang Y; Xue N; Du T; Dong K; Yao X; Jin J; Feng Z; Chen X
    Acta Pharm Sin B; 2023 Jul; 13(7):3178-3179. PubMed ID: 37521865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum: Author correction to 'Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication' [Acta Pharmaceutica Sinica B 9 (2019) 769-781].
    Huang MH; Li H; Xue R; Li J; Wang L; Cheng J; Wu Z; Li W; Chen J; Lv X; Li Q; Lan P; Zhao L; Yang Y; Peng Z; Jiang J
    Acta Pharm Sin B; 2020 Jan; 10(1):195-196. PubMed ID: 31993316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erratum: Author correction to "A nanocleaner specifically penetrates the blood‒brain barrier at lesions to clean toxic proteins and regulate inflammation in Alzheimer's disease" [Acta Pharmaceutica Sinica B 12, (2021) 4032-4044].
    Lei T; Yang Z; Xia X; Chen Y; Yang X; Xie R; Tong F; Wang X; Gao H
    Acta Pharm Sin B; 2022 Jun; 12(6):2965-2967. PubMed ID: 35755290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum: Author correction to 'Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling' [Acta Pharmaceutica Sinica B 12 (2022) 1198-1212].
    Wu Y; Yu X; Wang Y; Huang Y; Tang J; Gong S; Jiang S; Xia Y; Li F; Yu B; Zhang Y; Kou J
    Acta Pharm Sin B; 2022 Jul; 12(7):3198-3199. PubMed ID: 35865100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erratum: Author correction to 'Design, synthesis and biological evaluation of chalcone analogues with novel dual antioxidant mechanisms as potential anti-ischemic stroke agents' [Acta Pharmaceutica Sinica B 9 (2019) 335-350].
    Wang J; Huang L; Chen C; Li G; Xie J; Shen M; Chen Q; Li W; He W; Qiu P; Wu J
    Acta Pharm Sin B; 2022 Aug; 12(8):3451-3452. PubMed ID: 35967280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erratum: Author correction to 'Actively priming autophagic cell death with novel transferrin receptor-targeted nanomedicine for synergistic chemotherapy against breast cancer' [Acta Pharmaceutica Sinica B 2019; 9(5):1061-1077].
    Mei D; Chen B; He B; Liu H; Lin Z; Lin J; Zhang X; Sun N; Zhao L; Wang X; Zhang Q
    Acta Pharm Sin B; 2020 Jun; 10(6):1143-1144. PubMed ID: 32642419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Erratum: Author correction to 'Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis
    Deng L; Petrek H; Tu MJ; Batra N; Yu AX; Yu AM
    Acta Pharm Sin B; 2023 Aug; 13(8):3577-3578. PubMed ID: 37655312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: Author correction to 'Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury
    Fan X; Mai C; Zuo L; Huang J; Xie C; Jiang Z; Li R; Yao X; Fan X; Wu Q; Yan P; Liu L; Chen J; Xie Y; Lai-Han Leung E
    Acta Pharm Sin B; 2023 Aug; 13(8):3575-3576. PubMed ID: 37655316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.